Text size Maddie Meyer / Getty Images Moderna’s shares have risen 239% so far this year, and the biotech company, which has no approved medications, has a market capitalization of more than $ 24 billion. But in a note sent out Monday morning, Jefferies analyst Michael Yee writes that the …
Read More »LG OLED CX TV review: pretty and expensive
Most of the new TVs are very good. So good that I have a hard time telling my friends, family and readers to spend more than a thousand dollars on any of them. This is because you can easily get a fantastic TV capable of offering the best picture quality …
Read More »Moderna’s stock falls due to the report of the delay in the Covid-19 vaccine trial
Text size Joseph Prezioso / Getty Images Shares of Modern biotechnology fell 6.2% on Thursday afternoon after health news website Stat reported that the company was delaying the start of a Phase 3 trial of its experimental Covid-19 vaccine. The report, based on quotes from unidentified sources described as “investigators,” …
Read More »Exxon Mobil unveiled an 8K Thursday. What was not in the presentation could be worrying.
Text size Scott Olson / Getty Images Exxon Mobil provided an update on its second-quarter outlook on Thursday, and could mean a second-quarter earnings release for the oil giant, according to Cowen & Company. In its latest 8K presentation, Exxon (ticker: XOM) detailed the continuing headwinds against the Covid-19 pandemic …
Read More »Pfizer’s shares rise as the company reveals the timeline for the coronavirus vaccine.
Text size Daniel Acker / Bloomberg Shares of the large pharmaceutical company Pfizer continue to rise one day after the company revealed promising and detailed data on a trial of its experimental vaccine Covid-19. Analysts said the highly aggressive timeline the company outlined on Wednesday was exciting, but far from …
Read More »